Skip to main content

Journal sections

Submissions are invited in all areas of human health and disease studied from a high-throughput perspective, including:

Genomics & epigenomics of disease

  • Medical and personal genomics
  • Exome and whole genome sequencing
  • Molecular cytogenomics
  • Transcriptomics
  • Epigenomics
  • Structural variation
  • Functional genomics 

Pharmacogenomics & personalized medicine

  • Pharmacogenomics
  • Toxicogenomics
  • Molecular diagnostics
  • Biomarker translation and testing
  • Biological and small molecule therapeutics
  • Molecular-targeted interventions including gene therapy
  • Nutrigenomics

Genomic epidemiology & public health genomics

  • Quantitative genetics
  • Statistical methods
  • Genome-wide association studies, systematic reviews and meta-analyses
  • Technology evaluation
  • Health services and implementation research
  • Health surveillance and epidemic monitoring
  • Outcomes and cost-effectiveness studies

Proteomics & metabolomics in medicine

  • Proteomics
  • Metabolomics and metabonomics
  • Lipidomics
  • Glycomics

Systems medicine & informatics

  • Systems approaches to disease and personalised medicine
  • Pathway, network and interactome analyses
  • Data integration and modelling
  • Methods, software and databases for genome-scale data
  • Translational bioinformatics
  • Decision-support systems for healthcare management

Ethical, legal & social issues

  • Safety, consent, confidentiality, data protection and other ethical issues
  • Legal and regulatory frameworks for research and clinical testing
  • Implications of genomics and personalized medicine for health systems, society, and economics
  • Genetic counselling in the genomic era
  • Communication and engagement with stakeholders and the public
  • Education and training of healthcare professionals
  • Editorial Board
  • Editorial Team
  • Sign up for article alerts and news from this journal
  • Contact us
  • Announcements

    C19 Rapid Review initiative

    Genome Medicine has joined the C19 Rapid Review initiative, a cross-publisher collaboration to ensure that COVID-19 research is reviewed and published as quickly and openly as possible. Learn more here

    Submissions from medRxiv 

    Authors are now able to submit manuscripts to Genome Medicine directly from medRxiv without having to re-upload files.

    Portable peer review

    To reduce time spent on serial submissions and iterative reviewing, Genome Medicine offers to consider manuscripts on the basis of reviews received at other journals. We also support transfers of reviews obtained at Genome Medicine to other journals, including those outside of BMC and Springer Nature. Learn more from our peer review policy page.

    COVID-19 submissions

    In response to the current SARS-CoV-2 pandemic Genome Medicine editors will treat relevant submissions with high priority.